O(6)-benzylguanine: all 30 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)RecruitingNCT05052957Phase 2
- O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell LymphomaCompletedNCT00961220Phase 1/2Results posted
- O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant GliomasTerminatedNCT00669669Phase 1/2Results posted
- O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation TherapyTerminatedNCT00436436Phase 2Results posted
- O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem TumorsCompletedNCT00275002Phase 2Results posted
- HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionWithdrawnNCT02343666Phase 1
- Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWithdrawnNCT01769911Not applicable
- Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant GliomaCompletedNCT00613093Phase 2
- Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBMCompletedNCT00612989Phase 1
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaTerminatedNCT00389090Phase 2
- Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid TumorsTerminatedNCT00086970Phase 1
- Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
- Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma MultiformeWithdrawnNCT00046878Phase 2
- Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant GliomaTerminatedNCT00045721Phase 1
- Temozolomide and O6-benzylguanine in Treating Children With Solid TumorsCompletedNCT00020150Phase 1
- S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or GliosarcomaCompletedNCT00017147Phase 3
- Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic GliomaCompletedNCT00006474Phase 1
- Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00005981Phase 2
- O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic MelanomaCompletedNCT00005961Phase 2
- Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive GliomaCompletedNCT00005081Phase 2
- O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue SarcomaCompletedNCT00005066Phase 2
- O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004892Phase 1
- O6-benzylguanine And Carmustine in Treating Patients With Multiple MyelomaCompletedNCT00004072Phase 2
- O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During SurgeryCompletedNCT00003766Phase 1
- O6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsCompletedNCT00003765Phase 1
- O6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaTerminatedNCT00003613Phase 1
- Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNCT00003567Phase 1
- Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the BrainCompletedNCT00003348Phase 1
- O(6)-Benzylguanine in Treating Patients With Malignant GliomaCompletedNCT00002971Phase 1
- O(6)-Benzylguanine and Carmustine in Treating Patients With Solid TumorsCompletedNCT00002604Phase 1